Citigroup
AHPI

Citigroup’s Allied Healthcare Products AHPI Stock Holding History

Citigroup’s Portfolio AHPI Stock Details AHPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-70
Closed – – 6113
2022
Q3 		$0 Buy
+70
New +$129 ﹤0.01% 6570

Other funds holding AHPI

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Citigroup's AHPI Position: Q4 2022 in Review

Citigroup sold out of Allied Healthcare Products (AHPI) in Q4 2022, closing a stake of 70 shares.

Citigroup first reported a position in AHPI in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 12 funds tracked by Wall St. Rank hold AHPI as of Q4 2022.

  • Citigroup reported no remaining Allied Healthcare Products position as of Q4 2022 after selling out during the quarter.
  • Citigroup sold 70 Allied Healthcare Products shares in Q4 2022.
  • Citigroup first reported a position in Allied Healthcare Products in Q3 2022 and held it in 1 quarter.
  • Citigroup's Allied Healthcare Products position peaked at $0 in Q3 2022.
  • 12 funds tracked by Wall St. Rank held Allied Healthcare Products as of Q4 2022.

Based on Citigroup's 13F filing for Q4 2022, filed 9 Feb 2023.